Brief: MEI Pharma, Inc. Rebrands as Lite Strategy, Inc., Adopts New NASDAQ Ticker ‘LITS’
10/09/2025 14:03
Sept 10 (Reuters) - MEI Pharma Inc MEIP.O: MEI PHARMA INC - REBRANDS AS LITE STRATEGY, ADOPTS NASDAQ TICKER 'LITS' MEI PHARMA INC - CO'S TICKER SYMBOL ON NASDAQ WILL TRANSITION EFFECTIVE AT MARKET OPEN ON SEPTEMBER 11, 2025 Source text: ID:nBw3ZHLPMa Further company coverage: MEIP.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lite Strategy
See all newsBrief: Lite Strategy Receives Governance Rights And Option To Buy Litvm Future Network Tokens
U.S. RESEARCH ROUNDUP- Equinix, KLA, WW Grainger
Brief: Lite Strategy Inc - On Nov 14, Board Approves Justin J. File As Permanent CEO - SEC Filing
Brief: Lite Strategy Reports First Quarter Fiscal Year 2026 Results Highlights Successful Launch Of $100M Litecoin Treasury Strategy And Movement Into Active Capital Market Operations
Brief: Lite Strategy Announces $25M Share Repurchase Program, Signaling Shift From Initial Litecoin Accumulation To Active Capital Market Operations